Browse Related Topics For:

Hatch-Waxman

74
Patents
49
Generic Drugs
43
Pharmaceutical
40
Pharmaceutical Patents
34
ANDA
34
Patent Infringement
31
Patent Litigation
27
FDA
27
FTC
26
Pharmaceutical Manufacturers
26
SCOTUS
24
Prescription Drugs
23
Reverse Payment Settlement Agreements
21
FTC v Actavis
13
Pay-For-Delay
11
Antitrust Litigation
10
Settlement
9
BPCIA
8
Anti-Competitive
8
Biosimilars
8
Drug Manufacturers
7
Actavis Inc.
7
Inter Partes Review Proceedings
7
Patent Trial and Appeal Board
7
Teva Pharmaceuticals
6
Mylan Pharmaceuticals
6
Safe Harbors
5
America Invents Act
5
Biologics
5
Cephalon
5
Declaratory Judgments
5
Infringement
5
Personal Jurisdiction
5
Popular
5
Prior Art
4
AstraZeneca
4
Claim Construction
4
FDCA
4
Obviousness
4
Patent Reform
4
Standard of Review
4
Teva v Sandoz
4
Watson Pharmaceuticals
3
Apotex
3
Appeals
3
Classen Immunotherapies
3
DaimlerChrysler v Bauman
3
De Novo Standard of Review
3
Healthcare
3
Preliminary Injunctions
3
Reverse Payments
3
Rule-of-Reason Analysis
3
Sandoz v Amgen
3
Unfair Competition
2
Amgen
2
Antitrust Provisions
2
Biologics Price Competition and Innovation Act of 2009
2
Biotechnology
2
Burden of Proof
2
CA Supreme Court
2
Cartwright Act
2
Corporate Counsel
2
Damages
2
Disgorgement
2
Doctrine of Equivalents
2
Elan Pharmaceuticals
2
Generic
2
GlaxoSmithKline
2
Intellectual Property Litigation
2
Jurisdiction
2
Manufacturers
2
Merck
2
Non-Practicing Entities
2
Novartis
2
Patent Applications
2
Preemption
2
Presumption of Validity
2
Product Hopping
2
Sandoz
2
Sherman Act
2
Subject Matter Jurisdiction
2
Takeda Pharmaceuticals
2
USPTO
1
Allergan Inc
1
AMP v Myriad
1
Annual Reports
1
Article III
1
Biofuel
1
Biogen Idec
1
Biopharmaceutical
1
Bowman v Monsanto
1
Brand
1
Broadest Reasonable Interpretation Standard
1
Burden-Shifting
1
Certiorari
1
Cipro
1
Claim Preclusion
1
Class Action
1
Clear and Convincing Evidence
1
Clear Error Standard
1
Clinical Trials
1
Coca Cola
1
Combination Products
1
Commercial Marketing
1
Competition
1
Consent Order
1
Consideration
1
Covered Business Method Proceedings
1
Crestor
1
Cuozzo Speed Technologies
1
DaimlerAG
1
Design Defects
1
Design Patent
1
Disclosure Requirements
1
Discovery
1
Discovery Schedule
1
Dismissals
1
DNA
1
Drug Approvals
1
Duty to Deal
1
eBay
1
Eli Lilly
1
Enforcement
1
Enforcement Actions
1
Enforcement Statistics
1
Exclusivity
1
Exemptions
1
Expert Testimony
1
Extrinsic Evidence
1
Failure To Warn
1
Fair Market Value
1
False Advertising
1
Federal Jurisdiction
1
Federal Rule 12(b)(6)
1
Forum
1
Forum Shopping
1
Fresenius
1
Genzyme
1
Hedge Funds
1
Human Genes
1
Induced Infringement
1
Injunctions
1
Innovation Act
1
Integra
1
Inter Partes Reexamination
1
InterDigital Communications v ITC
1
Inventions
1
Jazz Pharmaceuticals
1
Joinder
1
Justiciable Controversy
1
Labeling
1
Lanham Act
1
Life Sciences
1
Manufacturing Defects
1
Market Manipulation
1
Marketing
1
Mayo v. Prometheus
1
Medical Devices
1
Medicare Modernization Act
1
Minimum Contacts
1
Misrepresentation
1
Monopolization
1
Monsanto
1
Motion to Dismiss
1
Mutual Pharmaceuticals v Bartlett
1
Myriad
1
Noninfringement
1
Off-Label Use
1
Orange Book
1
Otsuka Pharmaceutical
1
Par Pharmaceutical
1
Par/Paddock
1
Patent Assertion Entities
1
Patent Dance
1
Patent Exhaustion
1
Patent Invalidity
1
Patent Trolls
1
Patent-Eligible Subject Matter
1
Patent-in-Suit
1
Patentability Search
1
Pfizer
1
PHRMA
1
Pleadings
1
POM Wonderful
1
Premarket Approval Applications
1
Price Manipulation
1
Prioritized Examination
1
Product Exclusivity
1
Product Labels
1
Proposed Amendments
1
Proposed Regulation
1
Regulatory Agenda
1
Reissue Patents
1
Restraint of Trade
1
Reversal
1
Ripeness
1
Rosuvastatin
1
Royalties
1
Rulemaking Process
1
Sales Contracts
1
Scope of the Patent Test
1
Shire Development v Watson
1
Standard of Proof
1
Standing
1
Supplemental Examination
1
The Consumer Relief Fund
1
Vacated
1
Vaccinations
1
Validity
1
Valuation
1
Vitiation Test
1
Written Descriptions